Back to news

TriSalus Life Sciences to Participate in the 38th Annual Piper Sandler Healthcare Conference on December 1, 2026

Business Wire•17/11/2026•16:05 ET
0

Key Highlights

  • ➤TriSalus will present at Piper Sandler’s 38th Annual Healthcare Conference on December 1, 2026
  • ➤CEO Mary Szela and CFO David Patience will hold one-on-one investor meetings
  • ➤Presentation scheduled for 8:10 a.m. ET, with webcast replay available for 90 days
  • ➤Company is completing data for several Phase 1 nelitolimod clinical trials
  • ➤TriSalus plans to explore development partnerships after Phase 1 data completion

Expert Statements

Mary Szela, Chief Executive Officer and President of TriSalus Life Sciences

“Management will participate in one-on-one meetings and present on Tuesday, December 1, at 8:10 a.m. ET.”

TriSalus Life Sciences to Participate in the 38th Annual Piper Sandler Healthcare Conference on December 1, 2026

TriSalus Life Sciences® Inc. (Nasdaq: TLSI) (“TriSalus” or the “Company”), an oncology company integrating novel medicine delivery technology with standard of care therapies to transform treatment for patients, today announced that Mary Szela, Chief Executive Officer and President, and David Patience, Chief Financial Officer, will participate in the Piper Sandler 38th Annual Healthcare Conference. Management will participate in one-on-one meetings and present on Tuesday, December 1, at 8:10 a.m. ET.

Get started

Create a free account to read the full story.

Sign Up

Already have an account? Log in